Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01158508 · ClinicalTrials.gov registry record · Phase 1
Remote Ischemic Preconditioning in Subarachnoid Hemorrhage
A Phase 1 study of Subarachnoid Hemorrhage and Intracranial Aneurysm, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT01158508: Completed Phase 1 study of Subarachnoid Hemorrhage and Intracranial Aneurysm, sponsored by University of California, Los Angeles.
NCT01158508 is a Phase 1 study of Subarachnoid Hemorrhage and Intracranial Aneurysm that has completed, run by University of California, Los Angeles. The registered enrollment target is 20 participants, below the 3,587-participant average among 21 other Subarachnoid Hemorrhage trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01158508, a Phase 1 study of Subarachnoid Hemorrhage and Intracranial Aneurysm, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Rupture of brain aneurysms is a common cause of death and disability, accounting for as many as 10% of stroke cases in the United States. While much of the resulting injury to the nervous system is caused by the initial bleeding from the aneurysm, many of these patients develop cerebral vasospasm, pathological constriction of the blood vessels supplying the brain, several days following hemorrhage. As many as a third of patients can suffer a resulting neurological deficit and stroke, presumably caused by the decreased blood flow to the brain (ischemia). This delayed brain injury accounts for a significant percentage of poor outcomes following aneurysm rupture. Studies have shown that remote ischemia to many organs can precondition other tissues (including the brain) to be more tolerant to decreases in blood flow. This "remote ischemic preconditioning" has the promise of protecting the brain from ischemic injury. Whereas in other forms of stroke the onset of ischemia cannot be predicted in the general population, following aneurysm rupture the investigators know which patients are likely to develop vasospasm and when. Therefore, ischemic preconditioning following aneurysm rupture may help prevent some of the ischemic injury caused by vasospasm. Remote ischemic preconditioning by transient limb ischemia (produced by inflation of a blood pressure cuff on the arm or leg) has been shown to minimize injury to other organs, most notably the heart. Remote ischemic preconditioning of the brain following aneurysm rupture has not yet been investigated.
Conditions Studied
Interventions
- PROCEDURE Remote ischemic preconditioning
Study Locations (1)
California
- UCLA Ronald Reagan Medical Center - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-04 |
| Est. Completion | 2014-07 |
| Phase | Phase 1 |
What the finished NCT01158508 record still lists
NCT01158508 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 3,587-participant average among 21 other Subarachnoid Hemorrhage trials with a reported enrollment target (99% lower).
The record links to 4 conditions, with Subarachnoid Hemorrhage appearing as the primary indexed condition, and to 1 intervention - of which Remote ischemic preconditioning is the first listed.
NCT01158508 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT01158508 about?
NCT01158508 is a clinical study titled "Remote Ischemic Preconditioning in Subarachnoid Hemorrhage". Rupture of brain aneurysms is a common cause of death and disability, accounting for as many as 10% of stroke cases in the United States. While much of the resulting injury to the nervous system is caused by the initial bleeding from the aneurysm, many of these patients develop cerebral vasospasm, p...
What is the current status of trial NCT01158508?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2010-04. Estimated completion is 2014-07.
What conditions does trial NCT01158508 study?
This clinical trial studies the following conditions: Subarachnoid Hemorrhage, Intracranial Aneurysm, Subarachnoid Hemorrhage, Aneurysmal, Cerebral Vasospasm.
What interventions are being tested in trial NCT01158508?
The interventions under investigation include: Remote ischemic preconditioning (PROCEDURE).
Who is sponsoring clinical trial NCT01158508?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01158508 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Subarachnoid Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01158508's enrollment target sits among peer trials
20 20th of 21 higher than 2 of 21 other Subarachnoid Hemorrhage trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Subarachnoid Hemorrhage trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury
RECRUITING · Phase 1
-
Prophylactic Antibiotics Useful With Antibiotic Impregnated External Ventricular Drains (EVDs)?
RECRUITING · Phase 1
-
A Randomized, Double-Blind, Placebo-Controlled Trial of Simvastatin on Subarachnoid Hemorrhage-Induced Vasospasm
COMPLETED · Phase 1
-
Subarachnoid Hemorrhage Recovery And Galantamine
COMPLETED · Phase 1
-
AFFECT Study for Patients With Intraventricular Hemorrhage, Subarachnoid Hemorrhage, Subdural Hematoma, and Ventriculitis
RECRUITING · NA
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia